7 completed, 1 recruiting, 1 terminated. 5 Phase 1, 3 Phase 2, 1 Early Phase 1, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 5 |
| Phase 2 | 3 | Completed 3 |
| Early Phase 1 | 1 | Recruiting 1 |
| Not applicable | 1 | Terminated 1 |
Follow Stage III Endometrial Carcinoma: new trials by email Literature Review of Stage III Endometrial Carcinoma trials Research Report on Stage III Endometrial Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Short-Course Radiation Therapy With Chemotherapy in People With Endometrial Cancer Intensity-modulated radiation therapy, Carboplatin, Paclitaxel - Endometrial Cancer, Stage III Endometrial Cancer | Early Phase 1 | Recruiting | Memorial Sloan Kettering Cancer Center | 28 | 2023-01-10 | 2026-06-25 |
| Lymph Node Mapping in Patients With Newly Diagnosed Endometrial Cancer Undergoing Surgery lymph node mapping, sentinel lymph node biopsy, isosulfan blue - Stage I Endometrial Carcinoma, Stage II Endometrial Carcinoma | Not applicable | Terminated | Case Comprehensive Cancer Center | 58 | 2013-07-01 | 2020-08-27 |
| Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 and Temsirolimus in Treating Patients With Advanced Solid Tumors temsirolimus, gamma-secretase/Notch signalling pathway inhibitor RO4929097, laboratory biomarker analysis - Endometrial Papillary Serous Carcinoma, Recurrent Endometrial Carcinoma | Phase 1 | Completed | National Cancer Institute (NCI) | 18 | 2010-08-01 | 2014-05-30 |
| Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors temsirolimus, vinorelbine ditartrate - Extensive Stage Small Cell Lung Cancer, Hereditary Paraganglioma | Phase 1 | Completed | University of Southern California | 19 | 2010-06-01 | 2016-06-13 |
| Stereotactic Radiosurgery Using CyberKnife in Treating Women With Advanced or Recurrent Gynecological Malignancies stereotactic radiosurgery, quality-of-life assessment - Fallopian Tube Cancer, Ovarian Sarcoma | Phase 2 | Completed | Case Comprehensive Cancer Center | 50 | 2009-05-01 | 2013-11-28 |
| Fludeoxyglucose (FDG) F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial Cancer fludeoxyglucose F 18, positron emission tomography, computed tomography - Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma | Phase 1 / Phase 2 | Completed | National Cancer Institute (NCI) | 384 | 2007-09-01 | 2019-07-23 |
| Temsirolimus, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Tumors paclitaxel, carboplatin, temsirolimus - Ovarian Sarcoma, Ovarian Stromal Cancer | Phase 1 | Completed | National Cancer Institute (NCI) | 38 | 2007-02-01 | 2014-06-19 |
| EF5 in Finding Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Cervical, Endometrial, or Ovarian Epithelial Cancer EF5 - Primary Peritoneal Cavity Cancer, Stage I Endometrial Carcinoma | Phase 2 | Completed | National Cancer Institute (NCI) | 60 | 2005-02-01 | 2013-01-16 |
| Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu recombinant interleukin-12, ABI-007/carboplatin/trastuzumab - Advanced Adult Primary Liver Cancer, Anaplastic Thyroid Cancer | Phase 1 | Completed | National Cancer Institute (NCI) | 15 | 1999-08-01 | 2013-02-28 |
Endometrial Neoplasms (9) · Carcinoma, Ovarian Epithelial (5) · Uterine Cervical Neoplasms (5) · Carcinoma, Renal Cell (3) · Breast Neoplasms (2) · Breast Neoplasms, Male (2) · Carcinoma, Islet Cell (2) · Carcinoma, Medullary (2) · Carcinoma, Non-Small-Cell Lung (2) · Fallopian Tube Neoplasms (2) · Prostatic Neoplasms (2) · Vaginal Neoplasms (2) · Vulvar Neoplasms (2) · Adenocarcinoma, Follicular (1) · Adrenocortical Carcinoma (1)
Female Urogenital Diseases (9) · Female Urogenital Diseases and Pregnancy Complications (9) · Genital Diseases (9) · Genital Diseases, Female (9) · Genital Neoplasms, Female (9) · Neoplasms (9) · Neoplasms by Site (9) · Urogenital Diseases (9) · Urogenital Neoplasms (9) · Uterine Diseases (9) · Uterine Neoplasms (9) · Carcinoma (6) · Neoplasms by Histologic Type (6) · Neoplasms, Glandular and Epithelial (6) · Adnexal Diseases (5)
Sirolimus (3) · temsirolimus (3) · Carboplatin (2) · Paclitaxel (2) · Sentinel Lymph Node Biopsy (2) · 2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide (1) · 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole (1) · Fluorodeoxyglucose F18 (1) · Indocyanine Green (1) · Interleukin-12 (1) · Interleukin-12 Subunit p35 (1) · Lymph Node Excision (1) · Magnetic Resonance Spectroscopy (1) · Radiosurgery (1) · Radiotherapy, Intensity-Modulated (1)
National Cancer Institute (NCI) (5) · Case Comprehensive Cancer Center (2) · Memorial Sloan Kettering Cancer Center (1) · University of Southern California (1)
United States (7) · Canada (3) · Japan (1) · South Korea (1)
Amit Oza (2) · Agustin Garcia (1) · Chad Michener, MD (1) · Christina Chu (1) · Kaled Alektair, MD (1) · Mostafa Atri (1) · Robert DeBernardo, MD (1) · William Carson (1)
R21CA099346 (1), U01CA076576 (1), U01CA132123 (1), U10CA027469 (1), U10CA180868 (1)